Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

1. Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment

   Journal Article

   Tuval-Kochen, L.; Paglin, S.; Keshet, G.; Lerenthal, Y.; Nakar, C.; Golani, T.; Toren, A.; Yahalom, J.; Pfeffer, R.; Lawrence, Y.
   PLoS ONE (2013)

   Fulltext@MSK | Save
2. Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: An analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008)

   Journal Article

   Nakar, C.; Cooper, D. L.; DiMichele, D.
   Haemophilia (2010)

   Fulltext@MSK | Save
3. 3G8 and GMA161, anti Fc gamma RIII inhibitory monoclonal antibodies in the treatment of chronic refractory ITP. (Summary of 2 pilot studies)

   Meeting Abstract

   Nakar, C. T.; Bussel, J. B.
   Blood (2009)

   Fulltext@MSK | Save